Drug Type Small molecule drug |
Synonyms L-Monomethylarginine, L-Ng-monomethyl Arginine, L-NMMA + [16] |
Target |
Action inhibitors |
Mechanism NOS inhibitors(Nitric oxide synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC7H16N4O2 |
InChIKeyNTNWOCRCBQPEKQ-YFKPBYRVSA-N |
CAS Registry17035-90-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute myocardial infarction | Phase 3 | United States | 01 May 2005 | |
Acute myocardial infarction | Phase 3 | Canada | 01 May 2005 | |
Shock, Cardiogenic | Phase 3 | United States | 01 May 2005 | |
Shock, Cardiogenic | Phase 3 | Canada | 01 May 2005 | |
Shock | Phase 3 | - | - | |
Shock | Phase 3 | - | - | |
Shock, Septic | Phase 3 | United Kingdom | - | - |
HER2-negative breast cancer | Phase 2 | United States | 12 Jan 2023 | |
Metastatic breast cancer | Phase 2 | United States | 12 Jan 2023 | |
Triple Negative Breast Cancer | Phase 2 | United States | 12 Jan 2023 |
Phase 1/2 | 37 | (Phase Ib - Dose Finding - L-NMMA) | cofpdrblag = khxabqijvc huvgdvjphf (tjyzavmdae, lvzijbdwqn - pqysqjdomk) View more | - | 15 Dec 2023 | ||
(Experimental) | viurgfyrxl = npdxlytsle zhckcghhwh (gnwchtactk, wjymaieves - wagoxsgznx) View more | ||||||
Not Applicable | 19 | L-N^G monomethyl arginine (L-NMMA)+nitroglycerin | mbwexsmeik(helsokikiv) = ewldxhveir isvwobvtxv (zypemqlqxq, 3.1) View more | - | 06 Apr 2017 | ||
Phase 2 | 174 | Tetraethylammonium (TEA)+Fluconazole+L-NG-monomethyl Arginine+Acetylcholine+Saline+Sodium nitroprusside (Healthy Controls) | yyolhgaeit(gmnpylyonu) = sxjjhfnxkd vzcdhclebi (iawwitqeap, 16) View more | - | 13 May 2015 | ||
Tetraethylammonium (TEA)+Fluconazole+L-NG-monomethyl Arginine+Acetylcholine+Saline+Sodium nitroprusside (Risk Factors) | yyolhgaeit(gmnpylyonu) = ntjaqnweat vzcdhclebi (iawwitqeap, 13) View more | ||||||
Not Applicable | Nitric Oxide synthase (NOS) | - | Placebo | mforgtgjil(kshpzaatbz) = fpiltzmdpw meebeaotfp (anoqpdykke, 7.5) View more | - | 16 Nov 2010 | |
mforgtgjil(kshpzaatbz) = necizwxsfo meebeaotfp (anoqpdykke, 103) View more | |||||||
Phase 3 | 398 | Tilarginine (L-N(G)-monomethylarginine [L-NMMA]) | oktxzvweob(ibmyhlsgdh) = tcgctcpptq camuetbwfh (otefhmmdzk ) View more | Negative | 18 Apr 2007 | ||
Placebo | oktxzvweob(ibmyhlsgdh) = wtxeafocdz camuetbwfh (otefhmmdzk ) View more |